Author Contributions: Study concept and design: Schmid, Vollenweider, Waeber, and Marques-Vidal. Acquisition of data: Vollenweider, Bastardot, and Waeber. Analysis and interpretation of data: Schmid and Marques-Vidal. Drafting of the manuscript: Schmid. Critical revision of the manuscript for important intellectual content: Vollenweider, Bastardot, Waeber, and Marques-Vidal. Statistical analysis: Schmid. Obtained funding: Vollenweider and Waeber. Administrative, technical, and material support: Bastardot. Study supervision: Marques-Vidal.
Financial Disclosure: Drs Vollenweider and Waeber received an unrestricted grant from GlaxoSmithKline to build the CoLaus study.
Funding/Support: The CoLaus study was supported by research grants from the Swiss National Science Foundation (grant 33CSCO-122661) from GlaxoSmithKline and the Faculty of Biology and Medicine of Lausanne, Switzerland.
Additional Contributions: We thank the participants in the Lausanne CoLaus study and the investigators who have contributed to the recruitment, in particular research nurses Yolande Barreau, Anne-Lise Bastian, Binasa Ramic, Martine Moranville, Martine Baumer, Marcy Sagette, Jeanne Ecoffey, Sylvie Mermoud, Nicole Bonvin, Laure Bovy, Nathalie Maurer, Vanessa Jaquet, and Nattawan Laverrière for data collection. No compensation was received for all persons named in the acknowledgment.